Ads
related to: causes of al amyloidosis treatment- About Kisunla™
Learn What Kisunla™ Is, How it
Works, and How It May Help.
- Official HCP Site
Official HCP Site
For Health Care Professionals.
- Support For You
Find Customized Support To Help You
Navigate Treatment With Kisunla.
- Safety Information
Full Safety And Prescribing Info.
Read Important Safety Information.
- En Español
Find Full Website
Available in Spanish.
- Sign Up
Subscribe To Our Emails To Stay
In The Know On Kisunla™.
- About Kisunla™
Search results
Results From The WOW.Com Content Network
AL amyloidosis is caused by the deposition of abnormal antibody free light chains. The abnormal light chains are produced by monoclonal plasma cells, and, although AL amyloidosis can occur without diagnosis of another disorder, it is often associated with other plasma cell disorders, such as multiple myeloma and Waldenström's macroglobulinemia. [6]
Treatment is geared towards decreasing the amount of the involved protein. [2] This may sometimes be achieved by determining and treating the underlying cause. [2] AL amyloidosis occurs in about 3–13 per million people per year and AA amyloidosis in about two per million people per year. [2]
The majority of treatment is aimed at preserving heart function and treating heart failure symptoms. [3] Light chain (AL-CM) Treatment: Since the cause of this subtype of cardiac amyloidosis is the excessive production of free light chains, the major goal of treatment is the reduction in concentration of light chains. [5]
AA amyloidosis is a form of amyloidosis, a disease characterized by the abnormal deposition of fibers of insoluble protein in the extracellular space of various tissues and organs. In AA amyloidosis, the deposited protein is serum amyloid A protein (SAA), an acute-phase protein which is normally soluble and whose plasma concentration is highest ...
LECT2 Amyloidosis (ALECT2) is a form of amyloidosis caused by the LECT2 protein. It was found to be the third most common (~3% of total) cause of amyloidosis in a set of more than 4,000 individuals studied at the Mayo Clinic; the first and second most common forms the disorder were AL amyloidosis and AA amyloidosis, respectively.
Treatments aimed at symptom relief are available, and include diuretics, pacemakers, and arrhythmia management. Thus, Senile systemic amyloidosis and familial amyloid polyneuropathy are often treatable diseases that are misdiagnosed. [9] [10] [11]
Ads
related to: causes of al amyloidosis treatment